Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Daud
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients With Refractory Advanced Cancers
Clinical Cancer Research
Cancer Research
Oncology
Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function
Nutrition and Cancer
Medicine
Nutrition
Oncology
Cancer Research
Dietetics
17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
The Hsp90 Inhibitor 17-(Allylamino)-17-Demethoxygeldanamycin Increases Cisplatin Antitumor Activity by Inducing P53-Mediated Apoptosis in Head and Neck Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Enhanced Recovery From Contraction-Induced Damage in Skeletal Muscles of Old Mice Following Treatment With the Heat Shock Protein Inducer 17-(Allylamino)-17-Demethoxygeldanamycin
Rejuvenation Research
Aging
Gerontology
Geriatrics
Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines
DNA and Cell Biology
Medicine
Genetics
Cell Biology
Molecular Biology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology